Stay updated on CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.

Latest updates to the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4. This appears to be a small site update rather than a change to the study information.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, signaling a newer build of the site. This likely reflects internal updates or fixes that do not alter the displayed study information.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a minor update to the page metadata or content.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded the page revision tag Revision: v3.6.2 and removed Revision: v3.6.0, reflecting an update to the page's revision history.SummaryDifference0.1%

- Check59 days agoChange DetectedNew sections/links were added: How to Read a Study Record, Common Questions, and How to Join a Study, and the page now states 'No longer looking for participants' to indicate recruitment has ended. The label for the Intervention/Treatment section was adjusted from 'Intervention / Treatment' and the page footer shows 'Revision: v3.6.0'.SummaryDifference0.6%

- Check66 days agoChange DetectedA minor revision update was applied to the site, updating the revision tag from v3.5.4 to v3.5.5, signaling a small behind-the-scenes update.SummaryDifference0.1%

Stay in the know with updates to CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.